2020-2025 Global Neurodegenerative Diseases Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

Neurodegenerative disease is an umbrella term for a range of conditions which primarily affect the neurons in the human brain.

Neurons are the building blocks of the nervous system which includes the brain and spinal cord. Neurons normally don’t reproduce or replace themselves, so when they become damaged or die they cannot be replaced by the body. Examples of neurodegenerative diseases include Parkinson’s, Alzheimer’s, and Huntington’s disease.

Neurodegenerative diseases are incurable and debilitating conditions that result in progressive degeneration and / or death of nerve cells. This causes problems with movement (called ataxias), or mental functioning (called dementias).

Dementias are responsible for the greatest burden of neurodegenerative diseases, with Alzheimer’s representing approximately 60-70% of dementia cases.
This report elaborates the market size, market characteristics, and market growth of the Neurodegenerative Diseases industry, and breaks down according to the type, application, and consumption area of Neurodegenerative Diseases. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Neurodegenerative Diseases in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Neurodegenerative Diseases market covered in Chapter 13:
Teva
Alector
Asubio Pharmaceutical
Addex Pharmaceutical
Yumanity Therapeutics
Novartis
AstraZeneca
H.Lundbeck A/S
Pfizer
UCB
Eisai
Boehringer Ingelheim
Amarin
Bayer
Biogen Idec
Merck
Bial

In Chapter 6, on the basis of types, the Neurodegenerative Diseases market from 2015 to 2025 is primarily split into:
NMDA
SSRIs
Dopamine Inhibitors

In Chapter 7, on the basis of applications, the Neurodegenerative Diseases market from 2015 to 2025 covers:
Parkinson’s Disease
Huntington Disease
Amyotrophic Lateral Sclerosis
Alzheimer’s Disease

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:

Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025